Amgen AMGN
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 80th percentile, 5-year average 26.7x
#2065 of 2972 stocks by PE (1 = cheapest)
Around its usual level · 42nd percentile, 5-year average 32.1x
#5126 of 5311 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 100th percentile, 5-year average 5.1x
#4173 of 5150 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 21.56 | – | 32.07 | 42% (cheaper than usual) | #5126 of 5311 (1 = cheapest) |
| PE | 28.94 | 27.73 | 26.70 | 80% (pricier than usual) | #2065 of 2972 (1 = cheapest) |
| PS | 6.61 | 6.27 | 5.09 | 100% (pricier than usual) | #4173 of 5150 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on AMGN.
Sign in to join the discussion.